Genpharmasec Schedules Board Meeting to Approve Q2 Results
Genpharmasec Ltd 路 Intimation 路 03 Nov 2026, 5:30 am
Genpharmasec Schedules Board Meeting to Approve Q2 Results Genpharmasec Limited has scheduled a Board of Directors meeting on 3rd Nov'26 to consider and approve the un-audited standalone and consolidated financial results, along with the Limited Review Report, for the quarter and half-year ended 30th Sep'26. In compliance with SEBI insider trading regulations, the trading window for dealing in company securities has been closed from 1st Oct'26 and will reopen 48 hours following the formal declaration of the financial results.
Original exchange filing (PDF)
More announcements from Genpharmasec Ltd
- Statement of deviation or variation in the use of proceeds of Rights Issue for the Quarter ended 30th September, 2026. 路 03 Nov 2026
- Outcome of the Meeting of Board of Directors held on Tuesday, 03rd November, 2026. 路 03 Nov 2026
- Unaudited Standalone & consolidated Financial Result of the company for the quarter & half year ended 30th September 2026. 路 03 Nov 2026
- Outcome of the Meeting of Board of Directors held on Tuesday, 03rd November, 2026. 路 03 Nov 2026
- Intimation under regulation 30 - Change of name of Subsidiary of the company. 路 14 Oct 2026
- Disclosure of Voting Results and Scrutinizers report of the 34th Annual General Meeting held on 29th September, 2026. 路 30 Sept 2026
- Submission of Proceeding of the 34th Annual General Meeting of the Member of the Genpharmasec Ltd held on Tuesday, 29th September, 2026. 路 29 Sept 2026
- Annual Report for Financial Year 2025-26. 路 07 Sept 2026
